LLY vs BAX
By Alex · Tickerpine
Eli Lilly and Company vs Baxter International Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | BAX |
|---|---|---|
| Price | $1,443.50 | $25.81 |
| Market cap | $1.29T | $13.35B |
| P/E ratio | 46.9 | — |
| ROE | 86.02% | -9.04% |
| Profit margin | 31.90% | -6.23% |
| Revenue growth | 38.60% | 5.00% |
| Dividend yield | 0.48% | 0.16% |
| Beta | 0.39 | 0.67 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs BAX in plain English
- LLY is the bigger company — about 96.3× the market cap of BAX.
- LLY earns a higher return on equity (86% vs -9%).
- LLY is growing revenue faster (39% vs 5%).
- LLY has the higher dividend yield (0.48% vs 0.16%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
BAX return calculator
See what $1,000 in Baxter International Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.